Dr. Michael Borowitz, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,024 | 3 | 52.6% |
| Unspecified | $2,086 | 1 | 15.6% |
| Travel and Lodging | $2,019 | 3 | 15.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 1 | 15.0% |
| Food and Beverage | $126.50 | 3 | 0.9% |
| Education | $90.50 | 2 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $9,385 | 8 | $0 (2021) |
| Beckman Coulter, Inc. | $3,870 | 3 | $0 (2017) |
| Blueprint Medicines Corporation | $90.50 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,064 | 3 | Amgen Inc. ($973.50) |
| 2020 | $6,086 | 3 | Amgen Inc. ($6,086) |
| 2019 | $240.09 | 3 | Amgen Inc. ($240.09) |
| 2017 | $5,956 | 4 | Beckman Coulter, Inc. ($3,870) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/07/2021 | Blueprint Medicines Corporation | — | Education | In-kind items and services | $59.00 | General |
| 07/07/2021 | Blueprint Medicines Corporation | — | Education | In-kind items and services | $31.50 | General |
| 05/21/2021 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $973.50 | General |
| Category: Oncology | ||||||
| 09/04/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Oncology | ||||||
| 04/22/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 03/03/2020 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $35.56 | General |
| Category: Oncology | ||||||
| 12/06/2019 | Amgen Inc. | Blincyto (Biological) | Travel and Lodging | In-kind items and services | $149.15 | General |
| Category: Oncology | ||||||
| 12/06/2019 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $59.81 | General |
| Category: Oncology | ||||||
| 12/06/2019 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: Oncology | ||||||
| 12/20/2017 | Amgen Inc. | Blincyto (Biological) | — | In-kind items and services | $2,085.98 | Research |
| Study: CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment • Category: Oncology | ||||||
| 09/14/2017 | Beckman Coulter, Inc. | DxC 700 AU (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Devices | ||||||
| 06/20/2017 | Beckman Coulter, Inc. | DxC 700 AU (Device) | Travel and Lodging | Cash or cash equivalent | $1,349.38 | General |
| Category: Devices | ||||||
| 06/20/2017 | Beckman Coulter, Inc. | DxC 700 AU (Device) | Travel and Lodging | Cash or cash equivalent | $520.57 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment | Amgen Inc. | $2,086 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 369 | 566 | $65,878 | $14,339 |
| 2022 | 8 | 692 | 991 | $120,566 | $28,488 |
| 2021 | 8 | 659 | 980 | $118,319 | $29,038 |
| 2020 | 8 | 605 | 879 | $109,504 | $27,606 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 38 | 193 | $16,226 | $4,358 | 26.9% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 45 | 46 | $13,694 | $2,971 | 21.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 83 | 97 | $17,132 | $2,930 | 17.1% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2023 | 30 | 30 | $7,305 | $1,382 | 18.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 38 | 39 | $5,352 | $1,107 | 20.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 67 | 83 | $3,217 | $804.58 | 25.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 68 | 78 | $2,952 | $786.17 | 26.6% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2022 | 113 | 127 | $35,941 | $8,935 | 24.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 63 | 267 | $19,758 | $6,229 | 31.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 141 | 163 | $29,045 | $4,923 | 16.9% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2022 | 59 | 63 | $13,545 | $2,971 | 21.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 64 | 68 | $8,636 | $1,947 | 22.5% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 123 | 140 | $4,900 | $1,441 | 29.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 114 | 141 | $4,935 | $1,405 | 28.5% |
| 88187 | Flow cytometry technique for dna or cell analysis, 2 to 8 markers | Facility | 2022 | 15 | 22 | $3,806 | $637.38 | 16.7% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 110 | 121 | $34,243 | $8,692 | 25.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 54 | 277 | $20,498 | $6,679 | 32.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 135 | 157 | $27,777 | $4,875 | 17.5% |
| 88188 | Flow cytometry technique for dna or cell analysis, 9 to 15 markers | Facility | 2021 | 58 | 70 | $15,050 | $3,613 | 24.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 55 | 56 | $7,112 | $1,643 | 23.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 111 | 142 | $4,970 | $1,455 | 29.3% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 118 | 134 | $4,690 | $1,412 | 30.1% |
| 88187 | Flow cytometry technique for dna or cell analysis, 2 to 8 markers | Facility | 2021 | 18 | 23 | $3,979 | $668.55 | 16.8% |
| 88189 | Flow cytometry technique for dna or cell analysis | Facility | 2020 | 103 | 118 | $33,394 | $8,648 | 25.9% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 52 | 229 | $16,946 | $5,666 | 33.4% |
About Dr. Michael Borowitz, M.D
Dr. Michael Borowitz, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689630733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Borowitz, M.D has received a total of $13,346 in payments from pharmaceutical and medical device companies, with $1,064 received in 2021. These payments were reported across 13 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($7,024).
As a Medicare-enrolled provider, Borowitz has provided services to 2,325 Medicare beneficiaries, totaling 3,416 services with total Medicare billing of $99,471. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Baltimore, MD
- Active Since 04/25/2006
- Last Updated 04/04/2023
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1689630733
Products in Payments
- Blincyto (Biological) $9,385
- DxC 700 AU (Device) $3,870
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Baltimore
Edward Mccarthy, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $190,443
Aatur Singhi
Anatomic Pathology & Clinical Pathology — Payments: $142,537
Robert Kurman, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $129,835
Brigitte Ronnett, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $127,823
Robert Anders, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $127,130
Jonathan Epstein, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $73,416